BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 28692855)

  • 1. Recuperation of slow walking in de novo Parkinson's disease is more closely associated with increased cadence, rather than with expanded stride length.
    Kwon KY; Lee HM; Kang SH; Pyo SJ; Kim HJ; Koh SB
    Gait Posture; 2017 Oct; 58():1-6. PubMed ID: 28692855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of gait hypokinesia in Parkinson's disease.
    Morris ME; Iansek R; Matyas TA; Summers JJ
    Brain; 1994 Oct; 117 ( Pt 5)():1169-81. PubMed ID: 7953597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in the stride length-cadence relation in parkinsonian gait.
    Morris M; Iansek R; Matyas T; Summers J
    Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait.
    Hausdorff JM; Schaafsma JD; Balash Y; Bartels AL; Gurevich T; Giladi N
    Exp Brain Res; 2003 Mar; 149(2):187-94. PubMed ID: 12610686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gait disorders in Parkinson's disease: and pathophysiological approaches].
    Moreau C; Cantiniaux S; Delval A; Defebvre L; Azulay JP
    Rev Neurol (Paris); 2010 Feb; 166(2):158-67. PubMed ID: 19616816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gait variability in Parkinson's disease: levodopa and walking direction.
    Bryant MS; Rintala DH; Hou JG; Collins RL; Protas EJ
    Acta Neurol Scand; 2016 Jul; 134(1):83-6. PubMed ID: 26399376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
    Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
    J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.
    Delval A; Krystkowiak P; Blatt JL; Labyt E; Dujardin K; Destée A; Derambure P; Defebvre L
    J Neurol; 2006 Jan; 253(1):73-80. PubMed ID: 16096818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease.
    Bryant MS; Rintala DH; Hou JG; Lai EC; Protas EJ
    NeuroRehabilitation; 2011; 29(3):247-52. PubMed ID: 22142758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locomotor response to levodopa in fluctuating Parkinson's disease.
    Moore ST; MacDougall HG; Gracies JM; Ondo WG
    Exp Brain Res; 2008 Feb; 184(4):469-78. PubMed ID: 17828529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Walking on a treadmill improves the stride length-cadence relationship in individuals with Parkinson's disease.
    Ambrus M; Sanchez JA; Fernandez-Del-Olmo M
    Gait Posture; 2019 Feb; 68():136-140. PubMed ID: 30476690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Nordic Walking restore the temporal organization of gait variability in Parkinson's disease?
    Warlop T; Detrembleur C; Buxes Lopez M; Stoquart G; Lejeune T; Jeanjean A
    J Neuroeng Rehabil; 2017 Feb; 14(1):17. PubMed ID: 28222810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gait in drug naïve patients with de novo Parkinson's disease--altered but symmetric.
    Grajić M; Stanković I; Radovanović S; Kostić V
    Neurol Res; 2015 Aug; 37(8):712-6. PubMed ID: 25916791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal gait pattern emerges during curved trajectories in high-functioning Parkinsonian patients walking in line at normal speed.
    Turcato AM; Godi M; Giardini M; Arcolin I; Nardone A; Giordano A; Schieppati M
    PLoS One; 2018; 13(5):e0197264. PubMed ID: 29750815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.
    Rochester L; Baker K; Nieuwboer A; Burn D
    Mov Disord; 2011 Feb; 26(3):430-5. PubMed ID: 21462258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease.
    Faist M; Xie J; Kurz D; Berger W; Maurer C; Pollak P; Lücking CH
    Brain; 2001 Aug; 124(Pt 8):1590-600. PubMed ID: 11459750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.
    Bryant MS; Rintala DH; Hou JG; Charness AL; Fernandez AL; Collins RL; Baker J; Lai EC; Protas EJ
    Neurol Res; 2011 Nov; 33(9):959-64. PubMed ID: 22080998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.
    Vieregge P; Stolze H; Klein C; Heberlein I
    J Neural Transm (Vienna); 1997; 104(2-3):237-48. PubMed ID: 9203085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia.
    Bartels AL; Balash Y; Gurevich T; Schaafsma JD; Hausdorff JM; Giladi N
    J Clin Neurosci; 2003 Sep; 10(5):584-8. PubMed ID: 12948464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Backward Gait is Associated with Motor Symptoms and Fear of Falling in Patients with
    Kwon KY; Park S; Lee HM; Park YM; Kim J; Kim J; Koh SB
    J Clin Neurol; 2019 Oct; 15(4):473-479. PubMed ID: 31591835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.